FRESENIUS SE & CO. KGAA 2023-18.10.28FRESENIUS SE & CO. KGAA 2023-18.10.28FRESENIUS SE & CO. KGAA 2023-18.10.28

FRESENIUS SE & CO. KGAA 2023-18.10.28

No trades
See on Supercharts

A351ZX analysis



Key facts


Issue date
Oct 18, 2023
Maturity date
Oct 18, 2028
Outstanding amount
‪275.00 M‬CHF
Face value
5,000.00CHF
Minimum denomination
5,000.00CHF
Coupon
2.96% (Fixed)
Yield to maturity
0.91%
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.